Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
JC viremia in natalizumab-treated patients with multiple sclerosis.
ICV-transplanted human glial precursor cells are short-lived yet exert immunomodulatory effects in mice with EAE.
The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers.
Self-Reported Fatigue and Energy Cost During Walking Are Not Related in Patients With Multiple Sclerosis.
A randomized trial of stress management for the prevention of new brain lesions in MS.
Epidermal pigmentation in the human lineage is an adaptation to ultraviolet radiation.
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.
Extracranial Venous Drainage Patterns in Patients with Multiple Sclerosis and Healthy Controls.
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
Twin studies and the heritability of MS: a conclusion.
Autonomic dysfunction: A unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D(3), and Epstein-Barr virus.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
[The comparative study of efficacy and tolerability of intramuscular introduction of beta-interferon-1a in adults and adolescents with remitting multiple sclerosis.]
New TYSABRI® data show earlier treatment and longer-term use result in significant reductions in MS disease activity
Evaluation of olfactory dysfunction in neurodegenerative diseases.
Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes.
A genome-wide association study in progressive multiple sclerosis.
Non-lesional white matter changes in pediatric multiple sclerosis and monophasic demyelinating disorders.
B-Cell Depletion Abrogates T Cell-Mediated Demyelination in an Antibody-Nondependent Common Marmoset Experimental Autoimmune Encephalomyelitis Model.
A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic.
The Impact of Lesion In-Painting and Registration Methods on Voxel-Based Morphometry in Detecting Regional Cerebral Gray Matter Atrophy in Multiple Sclerosis.
Graves' disease after treatment with Alemtuzumab for multiple sclerosis.
Prevalence of stress urinary incontinence in women with multiple sclerosis.
Comorbid Multiple Sclerosis and TDP-43 Proteinopathy in a Gulf War Sea Captain.
Pages
« first
‹ previous
…
136
137
138
139
140
141
142
143
144
…
next ›
last »